Threshold Pharmaceuticals
South San Francisco
About Threshold Pharmaceuticals
Threshold is a biotechnology company focused on the discovery and development of drugs targeting Tumor Hypoxia, the low oxygen condition found in microenvironments of most solid tumors. This approach offers broad potential to treat most solid tumors. By selectively targeting tumor cells, they are building a pipeline of drugs that hold promise to be more effective and less toxic to healthy tissues than conventional anticancer drugs.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $137.7M
- Funding stage: M&A
- Last round: Post-IPO Equity (Mar 2017)
- Ticker: nasdaq:THLD
- Website: thresholdpharm.com
- Phone: (650)474-8200
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/threshold-pharmaceuticals-101258 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.